N-[2-[(2,4-difluorophenyl)methyl]-1-oxo-3,4-dihydroisoquinolin-5-yl]-2-(3,5-dimethyl-1-adamantyl)acetamide
C30H34F2N2O2 — CID 25063619
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[(2,4-difluorophenyl)methyl]-1-oxo-3,4-dihydroisoquinolin-5-yl]-2-(3,5-dimethyl-1-adamantyl)acetamide
N-[2-[(2,4-difluorophenyl)methyl]-1-oxo-3,4-dihydroisoquinolin-5-yl]-2-(3,5-dimethyl-1-adamantyl)acetamide (PubChem CID 25063619) has the molecular formula C30H34F2N2O2 and a molecular weight of 492.61 g/mol. Its IUPAC name is N-[2-[(2,4-difluorophenyl)methyl]-1-oxo-3,4-dihydroisoquinolin-5-yl]-2-(3,5-dimethyl-1-adamantyl)acetamide.
Molecular Properties
| Compound Name | N-[2-[(2,4-difluorophenyl)methyl]-1-oxo-3,4-dihydroisoquinolin-5-yl]-2-(3,5-dimethyl-1-adamantyl)acetamide |
|---|---|
| PubChem CID | 25063619 |
| Molecular Formula | C30H34F2N2O2 |
| Molecular Weight | 492.61 g/mol |
| Exact Mass | 492.26 |
| IUPAC Name | N-[2-[(2,4-difluorophenyl)methyl]-1-oxo-3,4-dihydroisoquinolin-5-yl]-2-(3,5-dimethyl-1-adamantyl)acetamide |
| SMILES | CC12CC3CC(C)(C1)CC(CC(=O)Nc1cccc4c1CCN(Cc1ccc(F)cc1F)C4=O)(C3)C2 |
| InChI | InChI=1S/C30H34F2N2O2/c1-28-11-19-12-29(2,16-28)18-30(13-19,17-28)14-26(35)33-25-5-3-4-23-22(25)8-9-34(27(23)36)15-20-6-7-21(31)10-24(20)32/h3-7,10,19H,8-9,11-18H2,1-2H3,(H,33,35) |
| InChIKey | QEKIWWURHZSLHS-UHFFFAOYSA-N |
| XLogP | 6.49 |
| TPSA | 49.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.61 |
| LogP ≤ 5 | 6.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25063619 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.